Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl clinical trials

Explore recruiting subjects with relapsed refractory peripheral t cell lymphoma r r ptcl clinical trials.

Also recruiting in Europe

Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1-2, Open-Label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with Relapsed/Refractory Peripheral T-cell Lymphoma

France, Spain, Italy, Hungary, Poland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl trials by city

Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Toronto Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Vancouver Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Montreal Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Calgary Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Edmonton Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Ottawa Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Winnipeg Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Quebec City Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Hamilton Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Kitchener Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in London Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Halifax Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in New York Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Los Angeles Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Chicago Subjects With Relapsed Refractory Peripheral T Cell Lymphoma R R Ptcl in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease